Literature DB >> 12679463

Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.

M Kolehmainen1, M I J Uusitupa, E Alhava, M Laakso, H Vidal.   

Abstract

The aim was to study the effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue. Adipose tissue samples were collected from 30 massively obese subjects (10 men and 20 women) from omental, sc abdominal, and femoral depots. The mRNA expression of PPARgamma1, PPARgamma2, lipoprotein lipase, p85alpha phosphatidylinositol 3-kinase, and uncoupling protein 2 were quantified by reverse transcription-competitive PCR. The genotypes of Pro12Ala polymorphism were determined by single-strand conformation polymorphism analysis. The frequency of the Ala12 allele was 13.3% (8 Pro12Ala and 22 Pro12Pro). There were no differences in body weight, fat mass, and fasting serum leptin between the genotypes. The mRNA expression of p85alpha phosphatidylinositol 3-kinase was significantly lower in the omental fat of the Pro12Ala carriers than the Pro12Pro carriers (P < 0.01). It also appeared that PPARgamma2 expression was higher in men with Ala12 allele (P < 0.01). Interestingly, particularly in women, the expression of both PPARgamma splice variants was lower in omental than sc fat independently of the genotype (P < 0.05-0.01). The common Pro12Ala polymorphism of the PPARgamma2 gene has minor influence on mRNA expression of PPARgamma target genes in adipose tissue of obese subjects. Expression of both PPARgamma splice variants is dependent on fat depot: omental fat shows lower mRNA levels, compared with sc fat depots.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679463     DOI: 10.1210/jc.2002-020603

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.

Authors:  Simona Cataldi; Valerio Costa; Alfredo Ciccodicola; Marianna Aprile
Journal:  Curr Diab Rep       Date:  2021-04-18       Impact factor: 4.810

2.  PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.

Authors:  Valerio Costa; Maria Assunta Gallo; Francesca Letizia; Marianna Aprile; Amelia Casamassimi; Alfredo Ciccodicola
Journal:  PPAR Res       Date:  2010-09-08       Impact factor: 4.964

3.  Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm.

Authors:  Corey S Moran; Paula Clancy; Erik Biros; Bernardo Blanco-Martin; Pamela McCaskie; Lyle J Palmer; Danny Coomans; Paul E Norman; Jonathan Golledge
Journal:  Clin Endocrinol (Oxf)       Date:  2009-04-25       Impact factor: 3.478

4.  Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial.

Authors:  Jussi Pihlajamäki; Ursula Schwab; Dorota Kaminska; Jyrki Ågren; Johanna Kuusisto; Marjukka Kolehmainen; Jussi Paananen; Markku Laakso; Matti Uusitupa
Journal:  Genes Nutr       Date:  2015-10-07       Impact factor: 5.523

5.  Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.

Authors:  Michael Harris; Krithika Bhuvaneshwar; Thanemozhi Natarajan; Laura Sheahan; Difei Wang; Mahlet G Tadesse; Ira Shoulson; Ross Filice; Kenneth Steadman; Michael J Pishvaian; Subha Madhavan; John Deeken
Journal:  Pharmacogenet Genomics       Date:  2014-02       Impact factor: 2.089

6.  PPARG Pro12Ala Polymorphism with CKD in Asians: A Meta-Analysis Combined with a Case-Control Study-A Key for Reaching Null Association.

Authors:  Hsiang-Cheng Chen; Wei-Teing Chen; Tzu-Ling Sung; Dung-Jang Tsai; Chin Lin; Hao Su; Yuh-Feng Lin; Hung-Yi Chiu; Sui-Lung Su
Journal:  Genes (Basel)       Date:  2020-06-26       Impact factor: 4.096

7.  The Single Nucleotide Polymorphism PPARG2 Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients.

Authors:  Ana Paula Dos Santos Rodrigues; Lorena Pereira Souza Rosa; Hugo Delleon da Silva; Elisângela de Paula Silveira-Lacerda; Erika Aparecida Silveira
Journal:  J Obes       Date:  2018-12-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.